https://www.nytimes.com/2021/01/18/briefing/ By David

New Post Public Reply Private Reply Replies (1) Message Board
TedJ
455
https://www.nytimes.com/2021/01/18/briefing/

By David Leonhardt
Jan. 18, 2021, 6:27 a.m. ET

Good morning. We explain why the vaccine news is better than you may think.

‘We’re underselling the vaccine’

Early in the pandemic, many health experts — in the U.S. and around the world — decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.

Their motivation was mostly good. It sprung from a concern that people would rush to buy high-grade medical masks, leaving too few for doctors and nurses. The experts were also unsure how much ordinary masks would help.

But the message was still a mistake.

It confused people. (If masks weren’t effective, why did doctors and nurses need them?) It delayed the widespread use of masks (even though there was good reason to believe they could help). And it damaged the credibility of public health experts.

“When people feel as though they may not be getting the full truth from the authorities, snake-oil sellers and price gougers have an easier time,” the sociologist Zeynep Tufekci wrote early last year.

Now a version of the mask story is repeating itself — this time involving the vaccines. Once again, the experts don’t seem to trust the public to hear the full truth.

This issue is important and complex enough that I’m going to make today’s newsletter a bit longer than usual. If you still have questions, don’t hesitate to email me at themorning@nytimes.com.

‘Ridiculously encouraging’

Right now, public discussion of the vaccines is full of warnings about their limitations: They’re not 100 percent effective. Even vaccinated people may be able to spread the virus. And people shouldn’t change their behavior once they get their shots.

These warnings have a basis in truth, just as it’s true that masks are imperfect. But the sum total of the warnings is misleading, as I heard from multiple doctors and epidemiologists last week.

“It’s driving me a little bit crazy,” Dr. Ashish Jha, dean of the Brown School of Public Health, told me.

“We’re underselling the vaccine,” Dr. Aaron Richterman, an infectious-disease specialist at the University of Pennsylvania, said.

“It’s going to save your life — that’s where the emphasis has to be right now,” Dr. Peter Hotez of the Baylor College of Medicine said.

The Moderna and Pfizer vaccines are “essentially 100 percent effective against serious disease,” Dr. Paul Offit, the director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said. “It’s ridiculously encouraging.”

The details
Here’s my best attempt at summarizing what we know:

The Moderna and Pfizer vaccines — the only two approved in the U.S. — are among the best vaccines ever created, with effectiveness rates of about 95 percent after two doses. That’s on par with the vaccines for chickenpox and measles. And a vaccine doesn’t even need to be so effective to reduce cases sharply and crush a pandemic.

If anything, the 95 percent number understates the effectiveness, because it counts anyone who came down with a mild case of Covid-19 as a failure. But turning Covid into a typical flu — as the vaccines evidently did for most of the remaining 5 percent — is actually a success. Of the 32,000 people who received the Moderna or Pfizer vaccine in a research trial, do you want to guess how many contracted a severe Covid case? One.

Although no rigorous study has yet analyzed whether vaccinated people can spread the virus, it would be surprising if they did. “If there is an example of a vaccine in widespread clinical use that has this selective effect — prevents disease but not infection — I can’t think of one!” Dr. Paul Sax of Harvard has written in The New England Journal of Medicine. (And, no, exclamation points are not common in medical journals.) On Twitter, Dr. Monica Gandhi of the University of California, San Francisco, argued: “Please be assured that YOU ARE SAFE after vaccine from what matters — disease and spreading.”

The risks for vaccinated people are still not zero, because almost nothing in the real world is zero risk. A tiny percentage of people may have allergic reactions. And I’ll be eager to see what the studies on post-vaccination spread eventually show. But the evidence so far suggests that the vaccines are akin to a cure.

Offit told me we should be greeting them with the same enthusiasm that greeted the polio vaccine: “It should be this rallying cry.”

The costs of negativity
Why are many experts conveying a more negative message?

Again, their motivations are mostly good. As academic researchers, they are instinctively cautious, prone to emphasizing any uncertainty. Many may also be nervous that vaccinated people will stop wearing masks and social distancing, which in turn could cause unvaccinated people to stop as well. If that happens, deaths would soar even higher.

But the best way to persuade people to behave safely usually involves telling them the truth. “Not being completely open because you want to achieve some sort of behavioral public health goal — people will see through that eventually,” Richterman said. The current approach also feeds anti-vaccine skepticism and conspiracy theories.

After asking Richterman and others what a better public message might sound like, I was left thinking about something like this:

We should immediately be more aggressive about mask-wearing and social distancing because of the new virus variants. We should vaccinate people as rapidly as possible — which will require approving other Covid vaccines when the data justifies it.

People who have received both of their vaccine shots, and have waited until they take effect, will be able to do things that unvaccinated people cannot — like having meals together and hugging their grandchildren. But until the pandemic is defeated, all Americans should wear masks in public, help unvaccinated people stay safe and contribute to a shared national project of saving every possible life.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Crossware Joins Ingram Micro Platform for Wider Reach

Updated Category News Views 3

Email Signature Game Changer Taps New Markets What goes around comes around, they say. Well, in the email signature business, it seems Crossware is putting that old adage to bed by building a highway straight through Ingram Micro's Xvantage platform. Yep, Crossware's shaking hands with Ingram to spread its email signature prowess to even more necks of the woods,...

Continue Reading
HoneyNaps Unveils Wireless PSG: Sleep Testing Revolution

Updated Category News Views 3

Tearing Down the Wired Wall in Sleep Studies Well, here's a switch-up that's long overdue in the world of sleep disorders diagnostics. It looks like HoneyNaps has figured out how to ditch the tangled mess that is traditional polysomnography (PSG) with their new creation—a wireless PSG system, and I gotta say, I'm liking the sound of that. If you've ever been strapped to...

Continue Reading
PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Updated Category News Views 2

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Continue Reading
Sotheby's to Auction Largest Flawless Paraiba Tourmalines

Updated Category News Views 0

Jaw-Dropping Gemstones Poised for Auction Glory The art of gemology isn't just about shiny rocks; it's a concoction of beauty, rarity, and, most importantly, value. And when the world's finest stones hit the auction block, it's akin to an epic performance in a long-awaited drama. On September 17, 2026, these precious Paraiba Tourmalines, fashioned by the adept hands of...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
SimpliTrain's Momentum in LMS Market Heating Up

Updated Category News Views 0

SimpliTrain Finds its Groove in the LMS Arena Out here in Delray Beach, SimpliTrain's making waves in the Learning Management System (LMS) market, recently snagging the 'Pervasive Player' tag from MarketsandMarkets' 360Quadrants platform. This cloud-based learning powerhouse ain't just playing around; they're doubling down with expansion into AI and other fancy tech bits...

Continue Reading
Delisting Gray Wolf Sparks Heated Hunter Nation Debate

Updated Category News Views 1

Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...

Continue Reading
GoDaddy Faces Class Action: Investor Stakes High

Updated Category News Views 2

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Continue Reading
Luxury Air Celebrates 18 Years of Comfort Service

Updated Category News Views 2

Celebrating 18 Years: A Journey of Comfort It's not often you see a business weave itself so seamlessly into the fabric of its community. But that's exactly what Luxury Air A/C & Heating has done in Conroe, The Woodlands, and across Montgomery County. Hit 18 years in the HVAC game, and you've clearly nailed something other folks can't quite replicate. Guess there's no...

Continue Reading

Top 5 Most Recently Viewed Articles

Corero Network Security Revolutionizes DDoS Protection Flexibility

Updated Category News Views 144

Introducing Cloud-Native DDoS Orchestration Corero Network Security has launched a significant enhancement to its DDoS protection capabilities with the introduction of cloud-native orchestration. This new deployment option allows clients to achieve faster time to protection while improving the flexibility in managing their DDoS infrastructure. Businesses are seeking more...

Continue Reading
Karan Raturi Joins D2E Labs as COO to Enhance Marketplace Success

Updated Category News Views 178

D2E Labs Welcomes Karan Raturi as New Chief Operating Officer D2E Labs, a notable private equity-backed platform known for its performance-driven marketplace services, proudly announces the appointment of Karan Raturi as its Chief Operating Officer. This strategic hiring positions Karan to spearhead operational excellence across D2E Labs' diverse portfolio, which includes...

Continue Reading
Lithium Ionic's Commitment to Sustainability through UNGC Membership

Updated Category News Views 172

Lithium Ionic's Commitment to Global Sustainability Efforts Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) has taken a significant step towards sustainability by joining the United Nations Global Compact (UNGC), a prominent initiative aimed at promoting responsible business practices worldwide. This membership showcases Lithium Ionic's dedication to supporting...

Continue Reading
Seabourn's Upcoming Luxurious Ocean Voyages for 2027-2028

Updated Category News Views 149

Seabourn Unveils Exciting Ocean and Expedition Voyages for 2027–2028 Seabourn, a renowned leader in ultra-luxury and expedition travel, has launched an impressive lineup of ocean voyages and expedition itineraries for the years 2027 and 2028. Setting sail to hidden-gem ports and breathtaking destinations worldwide, these itineraries offer unforgettable experiences for...

Continue Reading
Cloud Computing Growth: IaaS & PaaS Expected to Thrive

Updated Category News Views 169

The Expansion of the IaaS & PaaS Market As businesses around the globe shift towards cloud solutions, the Infrastructure as a Service (IaaS) and Platform as a Service (PaaS) market is witnessing a remarkable transformation. Valued at USD 90.65 billion, the IaaS & PaaS sector is projected to soar to USD 226.23 billion by 2032, growing at an impressive compound annual...

Continue Reading